Missed a Mounjaro dose?

Eli Lilly's Mounjaro prescribing information states: "If a dose is missed, administer Mounjaro as soon as possible within 4 days (96 hours) after the missed dose. If more than 4 days have passed, skip the missed dose and administer the next dose on the regularly scheduled day." That's FDA-approved label language, not a clinical approximation. Within 96 hours: take it. Past 96 hours: skip it. There's no gray zone — the decision is yes or no based on elapsed time.

The 72-hour spacing rule runs alongside it. A second part of the same prescribing information specifies that two Mounjaro doses shouldn't come within 3 days (72 hours) of each other. If your scheduled day was Monday and you remember Wednesday, you're still within the catch-up window — but your next dose can't come until at least 72 hours after that Wednesday shot, meaning the earliest re-injection is Saturday. If your usual next shot day would fall sooner than that, shift it out to at least 72 hours past the catch-up dose; in most cases that's a one-time shift of a day or two before your schedule normalizes.

What "within 4 days" looks like on a calendar. Because the window is calculated from the exact time the dose was due, "four calendar days" is an approximation — for precision, count 96 hours from the actual missed time. As a rough guide: a Sunday-morning shot's window closes Thursday morning; a Monday-morning shot's window closes Friday morning. If 96 hours have passed since your missed injection time, skip the dose entirely.

A few hours to 24 hours late. The simplest case — take your injection now, whatever time of day it is. Your next dose stays on its original weekly day, since the gap to next week's scheduled shot is well over the 72-hour minimum. Log the dose, note the site, move on.

Two to three days late. You're still within the window, so take the missed injection. The difference now is that the 72-hour spacing rule affects your next dose: if your usual day was Monday and you catch up Wednesday or Thursday, make sure your following injection lands at least 72 hours after that catch-up shot — your next shot day may shift by a day or two for one cycle before returning to normal. Don't assume it automatically falls back on the usual day without checking the spacing.

Right at the edge — approaching 96 hours. If fewer than 96 hours have passed, the label supports taking it. At 96 hours or more, skip it. There's no flexibility built in beyond that cutoff — a dose taken outside the approved window provides no measurable clinical benefit and raises the risk of a spacing conflict with your next scheduled injection.

Missing the catch-up window doesn't mean compensating for it. The missed dose is gone — resume your regular weekly schedule as if it didn't happen. This is deliberate: a dose taken too close to your next scheduled injection stacks the medication in your system in a way that meaningfully increases nausea, vomiting, and abdominal discomfort, without adding measurable weight-loss or glycemic benefit. Skipping is the safe choice, not a failure.

Once the window has closed, your next injection falls on your original scheduled day — not earlier. Missed a Sunday shot and Thursday has passed without injecting? Your next dose is the following Sunday, on schedule as usual. Doubling up or taking extra to compensate is never the answer — it significantly increases GI side effects without accelerating progress. Your prescriber chose your current dose for reasons specific to you; it doesn't change based on last week's schedule.

Appetite and "food noise" return faster than expected. Tirzepatide's appetite-suppressing effect begins fading within days of a missed injection — hunger becomes more present, cravings feel louder. This is a straightforward pharmacological response as drug levels drop, not a reflection of willpower. It stabilizes again within days of your next dose.

Blood sugar, for people managing type 2 diabetes. A gap in dosing can let blood sugar rise, sometimes noticeably. Watch for increased thirst, more frequent urination, blurry vision, fatigue, or headaches. A slight upward trend during the gap week isn't unusual and typically resolves after your next dose — but if readings climb significantly or you feel unwell, contact your prescriber rather than waiting for your next appointment.

GI changes when the next dose arrives. Some people notice mild nausea or stomach discomfort on the dose following a gap week, because tolerance dips slightly during the interruption. It's temporary. A single missed week generally doesn't require dose reduction or restarting titration, though persistent or severe symptoms are worth flagging to your provider.

Missed-dose rules across GLP-1 medications are not interchangeable, and the gap matters. Mounjaro (tirzepatide) gives a 96-hour catch-up window per its FDA label. Ozempic (semaglutide) allows 5 days per its own prescribing information. Wegovy's official guidance is framed differently again — it's forward-looking rather than a fixed window: take the missed dose only if your next scheduled dose is more than 48 hours away. These differences come directly from each drug's pharmacokinetics and labeling, and searching "GLP-1 missed dose" and applying the first result you find risks following the wrong protocol for your specific drug.

A Mounjaro user who applies Ozempic's 5-day rule might take a dose on day 5, a full day after their actual window closed. In either direction, the error pushes a dose outside its safety-tested window or disrupts spacing in a way that raises side-effect risk without clinical benefit. The safest approach is having the correct rule for your specific medication on hand — without searching, comparing, or trying to remember.

Missing one dose is a scheduling hiccup. Missing two or more consecutive weekly doses is roughly two weeks without tirzepatide, and your body's tolerance can shift — the dose that felt manageable before may trigger stronger GI side effects if resumed at the same amount. Contact your prescribing clinician before restarting rather than picking up where you left off.

After extended gaps — particularly four weeks or more — many clinicians recommend restarting at 2.5mg and re-titrating on the same schedule used when therapy began. This is practice-based guidance rather than label text, and it varies by provider and circumstance; the appropriate restart plan depends on how long the gap was, your prior dose, and whether you're using Mounjaro for weight management, diabetes, or both. This isn't a self-managed decision.

When you call, a simple factual summary is enough: how many consecutive doses you missed, approximate dates, any symptoms during the gap, and whether you're managing diabetes or weight loss. That's everything your prescriber needs to decide whether you resume at your current dose, step down temporarily, or restart titration.